Skip to main content
Drugwatch.com
  • Active Lawsuits
    • Lawsuits Directory
      • Prescription Drug Lawsuits
        • Depo-Provera Lawsuit
        • Oxbryta Lawsuit
        • Ozempic Lawsuit
        • Suboxone Lawsuit
        • Taxotere Lawsuits
        • Valsartan Lawsuits
      • Chemical Exposure Lawsuits
        • Aqueous Film Forming Foam (AFFF) Lawsuit
        • Dacthal (DCPA) Pesticide Lawsuit
        • Firefighter Gear PFAS Lawsuit
        • PFAS Water Contamination Lawsuit
      • Product Lawsuits
        • Chemical Hair Relaxer Lawsuit
        • NEC Baby Formula Lawsuit
        • Paraquat Lawsuit
        • Roundup Lawsuit
        • Talcum Powder Ovarian Cancer Lawsuits
      • Medical Device Lawsuits
        • Bard PowerPort Lawsuits
        • BioZorb Lawsuit
        • Hernia Mesh Lawsuit
        • Hip Replacement Lawsuits
        • Paragard Lawsuits
    • Injured by a prescription drug or defective medical device?
      Get a Free Case Review
  • Latest Legal News
    • News
    • Bayer Pharmaceutical Building
      Latest News
      A New Settlement for Roundup Lawsuits Could Be on the Horizon
      May 16, 2025
      Exterior of 3M office building
      Latest News
      3M Agrees to New Jersey PFAS Water Contamination Settlement Worth up to $450 Million
      May 14, 2025
      Gardener using Roundup on weeds
      Latest News
      Georgia Becomes Second State to Sign Law Limiting Roundup Lawsuits
      May 13, 2025
    • Drugwatch Investigations
    • Artistic illustration of a silhouette of a woman's head with a brain visible and a syringe pointed at the center, surrounded by flowers and dollar signs, symbolizing mental health and financial decisions.
      Featured Article
      Depo-Provera:
      A Convenient Shot, But at What Cost to Women’s Health?
    • Plaintiff Stories
    • Baby Formula bottle
      Latest Story
      Teen Still Deals With NEC Issues After Drinking Formula as a Baby Sixteen Years Ago
  • High-Risk Drugs & Devices
    • Drugs
      • Belviq
      • Depo-Provera
      • Hernia Mesh
      • Mounjaro (Tirzepatide)
      • Ozempic (Semaglutide)
      • Singulair
      • Suboxone
      • Taxotere
      • Tepezza
      • Truvada
      • Tylenol
    • Devices
      • Allergan Breast Implants
      • Bard PowerPort
      • Hip Replacements
      • IVC Filter
      • Transvaginal Mesh
      • Paragard
      • Valsartan
  • Who We Are
    • About Drugwatch
      • Our Team
        • Drugwatch Editorial Policy
        • Press Room
      • Our Trusted Legal Partners
        • Awards & Accreditations
    • Our Legal Experts
      • Man smiling, wearing a suit
        Brendan A. McDonough, Esquire Associate Attorney, Drug & Medical Device Litigation
      • Headshot of attorney Jonathan Sedgh
        Jonathan M. Sedgh, Esquire Mass Tort & Product Liability Attorney
      • Jayne Conroy, Named Shareholder of Simmons Hanly Conroy
        Jayne Conroy, Esquire Trial Attorney and Pharmaceutical Litigation Expert
      • Headshot of attorney, Trent Miracle.
        Trent B. Miracle, Esquire Mass Tort and Product Liability Attorney
    • Attorney Q&As
SPEAK WITH AN EXPERT
Call Now (888) 645-1617 Who Am I Calling?
(888) 645-1617Call Now
click to open search box

News – Page 8

  • Person testing for water contamination
    New EPA Proposal Would Add Over 100 PFAS to Toxics Release Inventory
    October 8, 2024
  • Baby bottle with formula on kitchen sink
    First Baby Formula Bellwether Trial Likely to Start in May 2025, per Proposal
    October 8, 2024
  • Paraquat
    Review of Highly Toxic Paraquat Pesticide Ordered in California
    October 3, 2024
  • Hernia mesh lawsuit settlement paperwork
    Becton Dickinson Announces Settlement to End “Vast Majority” of Hernia Mesh Lawsuits
    October 3, 2024
  • Woman having a hair product applied.
    Judge Allows Hair Relaxer Class Action Lawsuit to Move Forward
    October 2, 2024
  • Newborn infant drinking from bottle
    New Baby Formula Trial Gets Underway This Week, Could Inform Ongoing Lawsuits
    October 1, 2024
  • Baby Powder
    12 States Affected by Baby Powder Recall for Asbestos Contamination
    September 26, 2024
  • Johnson & Johnson Talcum Powder
    Will J&J’s Latest Talc Bankruptcy Plan Succeed? Several Factors at Play
    September 25, 2024
  • Baby bottle with formula on kitchen sink
    Baby Formula Lawsuits Moving Ahead with Bellwether Trial Order Set
    September 24, 2024
Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 81
Next
Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Who Am I Calling?

Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617
Subscribe to Our Newsletter

Join our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more.

Sign Up NowConnect with Drugwatch on Twitter
Navigate
  • Lawsuits
  • FDA
  • News
  • Drugs
  • About Us
  • Health Info
  • Devices
  • Drugwatch Podcast
  • Side Effects
  • Beyond Side Effects
Drugwatch.com

Help for people injured by defective drugs and medical devices

More About Us
  • (888) 645-1617 Who Am I Calling?
  • Connect with Drugwatch on Facebook
  • Connect with Drugwatch on Twitter
  • Connect with Drugwatch on Youtube
  • Contact Drugwatch by Email
  • Click for the BBB Business Review of Drugwatch.com, LLC
  • AMWA Member Logo
  • APHA Logo
  • AACI Logo

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

© 2025 Drugwatch.com Privacy Policy / Advertising Disclosure /

California Consumer Privacy Act (CCPA) Inquiries

Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.

Sorry there was an error. Please wait a moment and try again.
Sorry there is a continuing error in our system. Please call us using the phone number listed on this page.

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617